View Item 

Show simple item record

Frailty, Psychoactive Medications, and Cognitive Dysfunction Are Associated With Poor Patient‐Reported Outcomes in Cirrhosis
dc.contributor.authorTapper, Elliot B.
dc.contributor.authorBaki, Jad
dc.contributor.authorParikh, Neehar D.
dc.contributor.authorLok, Anna S.
dc.date.accessioned2019-04-02T18:11:08Z
dc.date.available2020-06-01T14:50:01Zen
dc.date.issued2019-04
dc.identifier.citationTapper, Elliot B.; Baki, Jad; Parikh, Neehar D.; Lok, Anna S. (2019). "Frailty, Psychoactive Medications, and Cognitive Dysfunction Are Associated With Poor Patient‐Reported Outcomes in Cirrhosis." Hepatology (4): 1676-1685.
dc.identifier.issn0270-9139
dc.identifier.issn1527-3350
dc.identifier.urihttps://hdl.handle.net/2027.42/148384
dc.publisherWiley Periodicals, Inc.
dc.titleFrailty, Psychoactive Medications, and Cognitive Dysfunction Are Associated With Poor Patient‐Reported Outcomes in Cirrhosis
dc.typeArticle
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelInternal Medicine and Specialties
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/148384/1/hep30336-sup-0001-Supinfo.pdf
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/148384/2/hep30336_am.pdf
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/148384/3/hep30336.pdf
dc.identifier.doi10.1002/hep.30336
dc.identifier.sourceHepatology
dc.identifier.citedreferenceDerck JE, Thelen AE, Cron DC, Friedman JF, Gerebics AD, Englesbe MJ, Sonnenday CJ. Quality of life in liver transplant candidates: frailty is a better indicator than severity of liver disease. Transplantation 2015; 99: 340 ‐ 344.
dc.identifier.citedreferenceCharlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373 ‐ 383.
dc.identifier.citedreferenceU.S. Preventive Services Task Force. Screening and behavioral counseling interventions in primary care to reduce alcohol misuse: recommendation statement. Ann Intern Med 2004; 140: 554 ‐ 556.
dc.identifier.citedreferenceKatz S. Assessing self‐maintenance: activities of daily living, mobility, and instrumental activities of daily living. J Am Geriatr Soc 1983; 31: 721 ‐ 727.
dc.identifier.citedreferenceBajaj JS, Hafeezullah M, Franco J, Varma RR, Hoffmann RG, Knox JF, et al. Inhibitory control test for the diagnosis of minimal hepatic encephalopathy. Gastroenterology 2008; 135: 1591 ‐ 1600.e1.
dc.identifier.citedreferenceAmodio P, Ridola L, Schiff S, Montagnese S, Pasquale C, Nardelli S, et al. Improving the inhibitory control task to detect minimal hepatic encephalopathy. Gastroenterology 2010; 139: 510 ‐ 518, 518.e1‐2.
dc.identifier.citedreferenceBeste LA, Leipertz SL, Green PK, Dominitz JA, Ross D, Ioannou GN. Trends in burden of cirrhosis and hepatocellular carcinoma by underlying liver disease in US veterans, 2001–2013. Gastroenterology 2015; 149: 1471 ‐ 1482.e5; quiz, e17‐18.
dc.identifier.citedreferenceTapper EB, Parikh ND. Mortality due to cirrhosis and liver cancer in the United States, 1999–2016: observational study. BMJ 2018; 362: k2817.
dc.identifier.citedreferenceCarey EJ, Steidley DE, Aqel BA, Byrne TJ, Mekeel KL, Rakela J, et al. Six‐minute walk distance predicts mortality in liver transplant candidates. Liver Transpl 2010; 16: 1373 ‐ 1378.
dc.identifier.citedreferencePatidar KR, Bajaj JS. Covert and overt hepatic encephalopathy: diagnosis and management. Clin Gastroenterol Hepatol 2015; 13: 2048 ‐ 2061.
dc.identifier.citedreferenceNabi E, Thacker LR, Wade JB, Sterling RK, Stravitz RT, Fuchs M, et al. Diagnosis of covert hepatic encephalopathy without specialized tests. Clin Gastroenterol Hepatol 2014; 12: 1384 ‐ 1389.e2.
dc.identifier.citedreferenceTapper EB, Parikh ND, Waljee AK, Volk M, Carlozzi NE, Lok AS. Diagnosis of minimal hepatic encephalopathy: a systematic review of point‐of‐care diagnostic tests. Am J Gastroenterol 2018; 113: 529 ‐ 538.
dc.identifier.citedreferenceDe Maeyer J, Vanderplasschen W, Broekaert E. Quality of life among opiate‐dependent individuals: a review of the literature. Int J Drug Policy 2010; 21: 364 ‐ 380.
dc.identifier.citedreferenceGould RL, Coulson MC, Patel N, Highton‐Williamson E, Howard RJ. Interventions for reducing benzodiazepine use in older people: meta‐analysis of randomised controlled trials. Br J Psychiatry 2014; 204: 98 ‐ 107.
dc.identifier.citedreferenceMaharshi S, Sharma BC, Sachdeva S, Srivastava S, Sharma P. Efficacy of nutritional therapy for patients with cirrhosis and minimal hepatic encephalopathy in a randomized trial. Clin Gastroenterol Hepatol 2016; 14: 454 ‐ 460.e3.
dc.identifier.citedreferenceRomán E, Torrades MT, Nadal MJ, Cárdenas G, Nieto JC, Vidal S, et al. Randomized pilot study: effects of an exercise programme and leucine supplementation in patients with cirrhosis. Digest Dis Sci 2014; 59: 1966 ‐ 1975.
dc.identifier.citedreferenceTrivedi HD, Tapper EB. Interventions to improve physical function and prevent adverse events in cirrhosis. Gastroenterol Rep (Oxf) 2018; 6: 13 ‐ 20.
dc.identifier.citedreferenceSchuppan D, Afdhal NH. Liver cirrhosis. Lancet 2008; 371: 838 ‐ 851.
dc.identifier.citedreferenceGines P, Quintero E, Arroyo V, Teres J, Bruguera M, Rimola A, et al. Compensated cirrhosis: natural history and prognostic factors. Hepatology 1987; 7: 122 ‐ 128.
dc.identifier.citedreferenceTapper E, Kanwal F, Asrani S, Ho C, Ovchinsky N, Poterucha J, et al. Patient reported outcomes in cirrhosis: a scoping review of the literature. Hepatology 2018; 67: 2375 ‐ 2383.
dc.identifier.citedreferenceArguedas MR, DeLawrence TG, McGuire BM. Influence of hepatic encephalopathy on health‐related quality of life in patients with cirrhosis. Digest Dis Sci 2003; 48: 1622 ‐ 1626.
dc.identifier.citedreferenceSolà E, Watson H, Graupera I, Turón F, Barreto R, Rodríguez E, et al. Factors related to quality of life in patients with cirrhosis and ascites: relevance of serum sodium concentration and leg edema. J Hepatol 2012; 57: 1199 ‐ 1206.
dc.identifier.citedreferenceVan Der Plas SM, Hansen BE, De Boer JB, Stijnen T, Passchier J, De Man RA, Schalm SW. Generic and disease‐specific health related quality of life in non‐cirrhotic, cirrhotic and transplanted liver patients: a cross‐sectional study. BMC Gastroenterol 2003; 3: 33.
dc.identifier.citedreferenceSanyal A, Younossi Z, Bass N, Mullen K, Poordad F, Brown R, et al. Randomised clinical trial: rifaximin improves health‐related quality of life in cirrhotic patients with hepatic encephalopathy—a double‐blind placebo‐controlled study. Aliment Pharmacol Ther 2011; 34: 853 ‐ 861.
dc.identifier.citedreferenceGhabril M, Jackson M, Gotur R, Weber R, Orman E, Vuppalanchi R, Chalasani N. Most individuals with advanced cirrhosis have sleep disturbances, which are associated with poor quality of life. Clin Gastroenterol Hepatol 2017; 15: 1271 ‐ 1278.e6.
dc.identifier.citedreferenceAcharya C, Betrapally N, Gillevet P, Sterling R, Akbarali H, White M, et al. Chronic opioid use is associated with altered gut microbiota and predicts readmissions in patients with cirrhosis. Aliment Pharmacol Ther 2017; 45: 319 ‐ 331.
dc.identifier.citedreferenceKrebs EE, Gravely A, Nugent S, Jensen AC, DeRonne B, Goldsmith ES, et al. Effect of opioid vs nonopioid medications on pain‐related function in patients with chronic back pain or hip or knee osteoarthritis pain: the SPACE randomized clinical trial. JAMA 2018; 319: 872 ‐ 882.
dc.identifier.citedreferenceTapper EB, Risech‐Neyman Y, Sengupta N. Psychoactive medications increase the risk of falls and fall‐related injuries in hospitalized patients with cirrhosis. Clin Gastroenterol Hepatol 2015; 13: 1670 ‐ 1675.
dc.identifier.citedreferenceBajaj JS, Thacker LR, Heuman DM, Sterling RK, Stravitz RT, Sanyal AJ, et al. Cognitive performance as a predictor of hepatic encephalopathy in pretransplant patients with cirrhosis receiving psychoactive medications: a prospective study. Liver Transpl 2012; 18: 1179 ‐ 1187.
dc.identifier.citedreferenceHayes CJ, Li X, Li C, Shah A, Kathe N, Bhandari NR, Payakachat N. Health‐related quality of life among chronic opioid users, nonchronic opioid users, and nonopioid users with chronic noncancer pain. Health Serv Res 2018; 53: 3329 ‐ 3349.
dc.identifier.citedreferenceSayer AA, Syddall HE, Martin HJ, Dennison EM, Roberts HC, Cooper C. Is grip strength associated with health‐related quality of life? Findings from the Hertfordshire Cohort Study. Age Ageing 2006; 35: 409 ‐ 415.
dc.identifier.citedreferenceGiné‐Garriga M, Roqué‐Fíguls M, Coll‐Planas L, Sitjà‐Rabert M, Salvà A. Physical exercise interventions for improving performance‐based measures of physical function in community‐dwelling, frail older adults: a systematic review and meta‐analysis. Arch Phys Med Rehabil 2014; 95: 753 ‐ 769.e.
dc.identifier.citedreferenceLai JC, Covinsky KE, Dodge JL, Boscardin WJ, Segev DL, Roberts JP, Feng S. Development of a novel frailty index to predict mortality in patients with end‐stage liver disease. Hepatology 2017; 66: 564 ‐ 574.
dc.identifier.citedreferenceLai JC, Dodge JL, Sen S, Covinsky K, Feng S. Functional decline in patients with cirrhosis awaiting liver transplantation: results from the functional assessment in liver transplantation (FrAILT) study. Hepatology 2016; 63: 574 ‐ 580.
dc.identifier.citedreferenceBoscarino JA, Lu M, Moorman AC, Gordon SC, Rupp LB, Spradling PR, et al. Predictors of poor mental and physical health status among patients with chronic hepatitis C infection: the Chronic Hepatitis Cohort Study (CHeCS). Hepatology 2015; 61: 802 ‐ 811.
dc.identifier.citedreferenceShiraki M, Nishiguchi S, Saito M, Fukuzawa Y, Mizuta T, Kaibori M, et al. Nutritional status and quality of life in current patients with liver cirrhosis as assessed in 2007–2011. Hepatol Res 2013; 43: 106 ‐ 112.
dc.identifier.citedreferenceKuroda H, Ushio A, Miyamoto Y, Sawara K, Oikawa K, Kasai K, et al. Effects of branched‐chain amino acid‐enriched nutrient for patients with hepatocellular carcinoma following radiofrequency ablation: a one‐year prospective trial. J Gastroenterol Hepatol 2010; 25: 1550 ‐ 1555.
dc.identifier.citedreferenceHays RD, Sherbourne CD, Mazel RM. The rand 36‐item health survey 1.0. Health Econ 1993; 2: 217 ‐ 227.
dc.identifier.citedreferenceBusija L, Pausenberger E, Haines TP, Haymes S, Buchbinder R, Osborne RH. Adult measures of general health and health‐related quality of life: Medical Outcomes Study Short Form 36‐Item (SF‐36) and Short Form 12‐Item (SF‐12) Health Surveys, Nottingham Health Profile (NHP), Sickness Impact Profile (SIP), Medical Outcomes Study Short Form 6D (SF‐6D), Health Utilities Index Mark 3 (HUI3), Quality of Well‐Being Scale (QWB), and Assessment of Quality of Life (AQOL). Arthritis Care Res (Hoboken) 2011; 63 ( Suppl 11 ): S383 ‐ S412.
dc.identifier.citedreferenceBuysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 1989; 28: 193 ‐ 213.
dc.identifier.citedreferenceMontagnese S, Middleton B, Skene DJ, Morgan MY. Sleep–wake patterns in patients with cirrhosis: All you need to know on a single sheet: a simple sleep questionnaire for clinical use. J Hepatol 2009; 51: 690 ‐ 695.
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
hep30336-sup-0001-Supinfo.pdf
Size:
294.0KB
Format:
PDF
View/Open
Name:
hep30336_am.pdf
Size:
200.8KB
Format:
PDF
View/Open
Name:
hep30336.pdf
Size:
277.6KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.